Upstream information
Description
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.SUSE information
Overall state of this security issue: Resolved
This issue is currently rated as having moderate severity.
| National Vulnerability Database | |
|---|---|
| Base Score | 5.4 |
| Vector | AV:A/AC:M/Au:N/C:P/I:P/A:P |
| Access Vector | Adjacent Network |
| Access Complexity | Medium |
| Authentication | None |
| Confidentiality Impact | Partial |
| Integrity Impact | Partial |
| Availability Impact | Partial |
Status of this issue by product and package
Please note that this evaluation state might be work in progress, incomplete or outdated. Also information for service packs in the LTSS phase is only included for issues meeting the LTSS criteria. If in doubt, feel free to contact us for clarification. The updates are grouped by state of their lifecycle. SUSE product lifecycles are documented on the lifecycle page.
| Product(s) | Source package | State |
|---|---|---|
| Products past their end of life and not receiving proactive updates anymore. | ||
| SLES for SAP Applications 11 SP3 | bash | Released |
| SUSE Linux Enterprise Server 11 SP3 | bash | Affected |
| SUSE Linux Enterprise Server 11 SP3 LTSS | bash | Released |
| SUSE Linux Enterprise Server 11 SP3-LTSS | bash | Affected |
SUSE Timeline for this CVE
CVE page created: Fri Sep 26 15:18:18 2014CVE page last modified: Fri Oct 13 19:04:55 2023